Alignment Healthcare, Inc.

NASDAQ:ALHC

13.78 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 692.433681.286628.601465.387456.709462.379439.155361.811360.348366.474345.526298.274293.466308.951267.082242.409247.867244.313224.633
Cost of Revenue 613.444605.312573.218417.762397.879410.644396.315326.002312.85307.269303.758259.571253.99274.385251.095215.014190.08194.502193.396
Gross Profit 78.98975.97455.38347.62558.8351.73542.8435.80947.49859.20541.76838.70339.47634.56615.98727.39557.78749.81131.237
Gross Profit Ratio 0.1140.1120.0880.1020.1290.1120.0980.0990.1320.1620.1210.130.1350.1120.060.1130.2330.2040.139
Reseach & Development Expenses 0000000000000000000
General & Administrative Expenses 00076.78100075.2700074.500049.614000
Selling & Marketing Expenses 0006.9560007.9580003.5810001.505000
SG&A 90.87187.86390.51283.73783.08970.19970.40883.22876.45261.67374.29378.08176.84671.1564.91451.11938.79433.69832.787
Other Expenses 7.64-94.356-96.4890.1420.1450.4284.9214.6874.4564.183.950.0840.0480.0590.0380.0380.057-0.03-0.797
Operating Expenses 98.51194.35696.48989.53888.58675.39475.32987.91580.90865.85378.24382.16980.92675.05868.65155.1942.72737.22436.352
Operating Income -19.522-18.382-41.106-41.913-29.756-23.659-32.489-52.106-33.41-6.648-36.475-43.466-41.45-40.492-52.664-27.79515.0612.587-5.115
Operating Income Ratio -0.028-0.027-0.065-0.09-0.065-0.051-0.074-0.144-0.093-0.018-0.106-0.146-0.141-0.131-0.197-0.1150.0610.052-0.023
Total Other Income Expenses Net -6.915-23.981-46.5750.1420.1450.428-4.881-4.717-6.67-4.932-4.3420.0840.0480.0590.0380.0380.057-0.03-0.797
Income Before Tax -26.437-23.981-46.575-47.255-35.077-28.493-37.37-56.823-40.08-11.58-40.817-47.834-45.816-44.762-56.874-32.06510.8468.365-10.072
Income Before Tax Ratio -0.038-0.035-0.074-0.102-0.077-0.062-0.085-0.157-0.111-0.032-0.118-0.16-0.156-0.145-0.213-0.1320.0440.034-0.045
Income Tax Expense -0.0080.022-0.054-0.024-0.030.0010.0010.1720.1674.9324.3424.5364.4624.3884.2864.3464.3284.1623.363
Net Income -26.413-24.01-46.521-47.209-35.047-28.477-37.371-56.995-40.247-16.512-45.159-47.834-45.816-44.762-56.874-32.06510.8468.365-10.072
Net Income Ratio -0.038-0.035-0.074-0.101-0.077-0.062-0.085-0.158-0.112-0.045-0.131-0.16-0.156-0.145-0.213-0.1320.0440.034-0.045
EPS -0.14-0.13-0.25-0.25-0.19-0.15-0.2-0.31-0.22-0.091-0.25-0.27-0.26-0.25-0.37-0.210.0710.055-0.066
EPS Diluted -0.14-0.13-0.25-0.25-0.19-0.15-0.2-0.31-0.22-0.091-0.25-0.27-0.26-0.25-0.37-0.210.0710.055-0.066
EBITDA -11.814-11.751-35.119-35.91-24.05-17.967-27.369-47.343-28.766-2.861-32.423-39.294-37.269-36.471-48.837-23.619.13716.171-2.242
EBITDA Ratio -0.017-0.017-0.056-0.077-0.053-0.039-0.062-0.131-0.08-0.008-0.094-0.132-0.127-0.118-0.183-0.0970.0770.066-0.01